Bridgeway Capital Management’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
Other funds holding IMI
RCM
GLAM
GF
GCIA
RAM
WIC
HIM
KPF
Bridgeway Capital Management's IMI Position: Q2 2019 in Review
Bridgeway Capital Management sold out of Intermolecular, Inc. (IMI) in Q2 2019, closing a stake of 313,100 shares — an estimated $360K sold.
Bridgeway Capital Management first reported a position in IMI in Q4 2013 and held it in 22 quarters. The position peaked at $879K in Q1 2016. 40 funds tracked by Wall St. Rank hold IMI as of Q2 2019.
- Bridgeway Capital Management reported no remaining Intermolecular, Inc. position as of Q2 2019 after selling out during the quarter.
- Bridgeway Capital Management sold 313,100 Intermolecular, Inc. shares in Q2 2019, an estimated $360K.
- Bridgeway Capital Management first reported a position in Intermolecular, Inc. in Q4 2013 and held it in 22 quarters.
- Bridgeway Capital Management's Intermolecular, Inc. position peaked at $879K in Q1 2016.
- 40 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2019.
Based on Bridgeway Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.